These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19346487)

  • 1. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity.
    van Montfoort N; Camps MG; Khan S; Filippov DV; Weterings JJ; Griffith JM; Geuze HJ; van Hall T; Verbeek JS; Melief CJ; Ossendorp F
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6730-5. PubMed ID: 19346487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct antigen uptake receptors route to the same storage compartments for cross-presentation in dendritic cells.
    Ho NI; Camps MG; Garcia-Vallejo JJ; Bos E; Koster AJ; Verdoes M; van Kooyk Y; Ossendorp F
    Immunology; 2021 Nov; 164(3):494-506. PubMed ID: 34110622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation.
    Cohn L; Chatterjee B; Esselborn F; Smed-Sörensen A; Nakamura N; Chalouni C; Lee BC; Vandlen R; Keler T; Lauer P; Brockstedt D; Mellman I; Delamarre L
    J Exp Med; 2013 May; 210(5):1049-63. PubMed ID: 23569326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
    Inaba K; Turley S; Iyoda T; Yamaide F; Shimoyama S; Reis e Sousa C; Germain RN; Mellman I; Steinman RM
    J Exp Med; 2000 Mar; 191(6):927-36. PubMed ID: 10727455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.
    Lizée G; Basha G; Tiong J; Julien JP; Tian M; Biron KE; Jefferies WA
    Nat Immunol; 2003 Nov; 4(11):1065-73. PubMed ID: 14566337
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Del Balzo D; Capmany A; Cebrian I; Damiani MT
    Front Immunol; 2021; 12():662096. PubMed ID: 33936099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation.
    Grotzke JE; Sengupta D; Lu Q; Cresswell P
    Curr Opin Immunol; 2017 Jun; 46():89-96. PubMed ID: 28528219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-dressing: an alternative mechanism for antigen presentation.
    Campana S; De Pasquale C; Carrega P; Ferlazzo G; Bonaccorsi I
    Immunol Lett; 2015 Dec; 168(2):349-54. PubMed ID: 26551033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI; Camps MGM; de Haas EFE; Ossendorp F
    Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells.
    Basha G; Lizée G; Reinicke AT; Seipp RP; Omilusik KD; Jefferies WA
    PLoS One; 2008 Sep; 3(9):e3247. PubMed ID: 18802471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
    André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
    J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of MHC class I recycling and Arf6 in cross-presentation by murine dendritic cells.
    Montealegre S; Abramova A; Manceau V; de Kanter AF; van Endert P
    Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31740564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
    Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
    Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.
    Song C; Noh YW; Lim YT
    Int J Nanomedicine; 2016; 11():3753-64. PubMed ID: 27540289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
    Montealegre S; van Endert PM
    Front Immunol; 2018; 9():3098. PubMed ID: 30666258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.
    Macri C; Dumont C; Panozza S; Lahoud MH; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
    Mol Immunol; 2017 Jan; 81():143-150. PubMed ID: 27978488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation.
    Cao X; Sugita M; Van Der Wel N; Lai J; Rogers RA; Peters PJ; Brenner MB
    J Immunol; 2002 Nov; 169(9):4770-7. PubMed ID: 12391186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential use of autophagy by primary dendritic cells specialized in cross-presentation.
    Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA
    Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioorthogonal deprotection on the dendritic cell surface for chemical control of antigen cross-presentation.
    Pawlak JB; Gential GP; Ruckwardt TJ; Bremmers JS; Meeuwenoord NJ; Ossendorp FA; Overkleeft HS; Filippov DV; van Kasteren SI
    Angew Chem Int Ed Engl; 2015 May; 54(19):5628-31. PubMed ID: 25784151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.